Safety and Tolerability Study in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Randomized, Placebo-Controlled, Double-Blind Six Month Study Followed by an Open-Label Extension Phase to Evaluate the Efficacy, Safety and Tolerability of MN-001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) A Randomized, Placebo-Controlled, Double-Blind Six Month Study Followed by an Open-Label Extension P ...